<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Our Meeting with the FDA</title>
	<atom:link href="http://eshareholderforum.com/oxbo/Chris_Stern/2008/12/11/our-meeting-with-the-fda/feed/" rel="self" type="application/rss+xml" />
	<link>http://eshareholderforum.com/oxbo/Chris_Stern/2008/12/11/our-meeting-with-the-fda/</link>
	<description></description>
	<pubDate>Sat, 04 Sep 2010 21:18:15 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6</generator>
		<item>
		<title>By: moneywize3</title>
		<link>http://eshareholderforum.com/oxbo/Chris_Stern/2008/12/11/our-meeting-with-the-fda/#comment-1</link>
		<dc:creator>moneywize3</dc:creator>
		<pubDate>Fri, 12 Dec 2008 12:23:06 +0000</pubDate>
		<guid isPermaLink="false">http://eshareholderforum.com/oxbo/Chris_Stern/?p=4#comment-1</guid>
		<description>I am very impressed that a company goes thru the effort to stay in contact with it's investors the way OXBO has chosen to do. From all the research I've been able to do on the history of Perfluorocarbons from the web, OXBO seems to have chosen a smart path to bring a drug to market and has the right people to achieve this. Hopefully the FDA gives the green light &#38; I am surprised with the casaulties of the Iraq war they haven't tried to fast track Oxycyte.
The topical route also seems to be a smart way to get to market quicker and appears to have many different applications as well. I was reading that herpes is an anaerobic virus and doesn't thrive in an oxygen environment. Hopefully the company will research this in the future as I am sure that could have huge market potential as well.
Hoping for the best, 
a new investor</description>
		<content:encoded><![CDATA[<p>I am very impressed that a company goes thru the effort to stay in contact with it&#8217;s investors the way OXBO has chosen to do. From all the research I&#8217;ve been able to do on the history of Perfluorocarbons from the web, OXBO seems to have chosen a smart path to bring a drug to market and has the right people to achieve this. Hopefully the FDA gives the green light &amp; I am surprised with the casaulties of the Iraq war they haven&#8217;t tried to fast track Oxycyte.<br />
The topical route also seems to be a smart way to get to market quicker and appears to have many different applications as well. I was reading that herpes is an anaerobic virus and doesn&#8217;t thrive in an oxygen environment. Hopefully the company will research this in the future as I am sure that could have huge market potential as well.<br />
Hoping for the best,<br />
a new investor</p>
]]></content:encoded>
	</item>
</channel>
</rss>
